Psoriatic eruption in Kawasaki disease

Journal of Pediatrics

Volumn 137, Issue 4, 2000, Pages 578-580

  Eberhard, B Anne ^a   Sundel, Robert P ^b   Newburger, Jane W ^b   Baker, Annette ^b   Fuhlbrigge, Robert C ^b   Burns, Jane C ^b   Gellis, Stephen E ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONVALESCENCE; HUMAN; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PSORIASIS; PUSTULAR PSORIASIS; PUSTULE;

EID: 0033754289     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.107840     Document Type: Article

References (16)

1. Taubert KA, Rowley AH, Shulman ST. Seven year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 1994; 13: 704-8.
2. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
3. Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. J Pediatr 1991; 118:680-6.
4. Brosius CL, Newburger JW, Burns JC, Hojnowski-Diaz P, Zierler S, Leung DYM. Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J 1988;7:863-6.
5. Arav-Boger R, Assia A, Jurgenson U, Spirer Z. The immunology of Kawasaki disease. Adv Pediatr 1994;41:359-67.
6. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumour necrosis factor, interleukin 2 receptor and interferon gamma m Kawasaki disease. Clin Immunol Immunopathol 1990;56:29-36.
7. Eberhard BA, Laxer RM, Andersson U, Silverman ED. Evaluation of the cytokine response in Kawasaki disease. Pediatr Infect Dis J 1995; 14:199-203.
8. Ortonne JP. Aetiology and pathogenesis of psoriasis. Br J Dermatol 1996; 135:(Suppl 49):1-5.
9. Christopners E. The Immunopathology of psoriasis. Int Aren Allergy Immunol 1996:110:199-206.
10. Norris DA, Travers JB, Leung DYM. Lymphocyte activation in the pathogenesis of psoriasis. J Invest Dermatol 1997:109:1-4.
11. Valdimarsson H, Sigmundsdottir H, Jonsdottir I. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross react with keratin? Clin Exp Immunol 1997;107(S1):21-4.
12. Leung DY, Travers JB, Norris DA. The role of superantigens in skin disease. J Invest Dermatol 1995; 105: 37S-42S.
13. Sakaguchi M, Kato H, Nishiyori A, Sagawa K, Itoh K. Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis alpha (TNF-α) by Vβ2+ or Vβ8- CD4+ T helper cells. Clin Exp Immunol 1992; 99:276-82.
14. Abe J, Kotzin BL, Meissner C, Melish ME, Fulton D, Romagne F, et al. Characterisation of T cell repertoire changes in acute Kawasaki disease. J Exp Med 1993:77:791-6.
15. Rotstein H. Psoriasis: changing clinical patterns. Aust J Dermatol 1996; 3781:S27-29.
16. Weigl BA. Immunoregulatory mechanisms and stress hormones in psoriasis (part 1). Int J Dermatol 1998;37: 350-7.